Lamictal 5mg dispersible tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Lamotrigine

Available from:

Sigma Pharmaceuticals Plc

ATC code:

N03AX09

INN (International Name):

Lamotrigine

Dosage:

5mg

Pharmaceutical form:

Dispersible tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 04080100

Patient Information leaflet

PACKAGE LEAFLET : INFORMATION FOR THE USER
LAMICTAL
_®_
5MG DISPERSIBLE/CHEWABLE TABLETS
(lamotrigine)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or
pharmacist.
This medicine has been prescribed for you only. Do not
pass it on to others. It may harm them, even if their signs
of illness are the same as yours.
If you get any of the side effects, talk to your doctor or
pharmacist. This includes any possible side effects not
listed in this leaflet. See section 4.
The name of your medicine is Lamictal 5mg
dispersible/chewable tablets but will be referred to as
Lamictal throughout this leaflet. Please note that the
leaflet also contains information about other strengths
Lamictal 2mg, 25mg and 100mg dispersible/chewable
tablets.
WHAT IS IN THIS LEAFLET
1
WHAT LAMICTAL IS AND WHAT IT IS USED FOR
2
WHAT YOU NEED TO KNOW BEFORE YOU TAKE LAMICTAL
3
HOW TO TAKE LAMICTAL
4
POSSIBLE SIDE EFFECTS
5
HOW TO STORE LAMICTAL
6
CONTENTS OF THE PACK AND OTHER INFORMATION
Lamictal belongs to a group of medicines called
_anti-epileptics_. It is used to treat two conditions - EPILEPSY
and BIPOLAR DISORDER.
LAMICTAL TREATS EPILEPSY by blocking the signals in the
brain that trigger epileptic seizures (fits)

For adults and children aged 13 years and over,
Lamictal can be used on its own or with other
medicines, to treat epilepsy. Lamictal can also be
used with other medicines to treat the seizures that
occur with a condition called Lennox-Gastaut
syndrome.

For children aged between 2 and 12 years, Lamictal
can be used with other medicines, to treat those
conditions. It can be used on its own to treat a type of
epilepsy called typical absence seizures.
LAMICTAL ALSO TREATS BIPOLAR DISORDER
People with bipolar disorder (sometimes called _manic _
_depression_) have extreme mood swings, with periods of_ _
mania (excitement or euphoria) alternating with peri

Summary of Product characteristics

PRODUCT SUMMARY
1.
NAME OF THE MEDICINAL PRODUCT
Not applicable
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Not applicable
3.
PHARMACEUTICAL FORM
Not applicable
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Not applicable
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Not applicable
4.3.
CONTRAINDICATIONS
Not applicable
4.4.
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Not applicable
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Not applicable
4.6.
PREGNANCY AND LACTATION
Not applicable
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Not applicable
4.8.
UNDESIRABLE EFFECTS
Not applicable
4.9.
OVERDOSE
Not applicable
5.
PHARMACOLOGICAL PROPERTIES
5.1.
PHARMACODYNAMIC PROPERTIES
Not applicable
5.2.
PHARMACOKINETIC PROPERTIES
Not applicable
5.3.
PRECLINICAL SAFETY DATA
Not applicable
6.
PHARMACEUTICAL PARTICULARS
6.1.
LIST OF EXCIPIENTS
Not applicable
6.2.
INCOMPATIBILITIES
Not applicable
6.3.
SHELF LIFE
Not applicable
6.4.
SPECIAL PRECAUTIONS FOR STORAGE
Not applicable
6.5.
NATURE AND CONTENTS OF CONTAINER
Not applicable
6.6.
INSTRUCTION FOR USE AND HANDLING (, AND DISPOSAL)
Not applicable
No Data Held
ADMINISTRATIVE DATA
7.
MARKETING AUTHORISATION HOLDER
Not applicable
8.
MARKETING AUTHORISATION NUMBER
Not applicable
9.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Not applicable
10.
DATE OF REVISION OF THE TEXT
Not applicable